Will symptomatic intracerebral hemorrhages decrease among eligible dabigatran-treated patients who receive intravenous tissue plasminogen activator for acute ischemic stroke?

Research output: Contribution to journalLetter

1 Citation (Scopus)
Original languageEnglish
Number of pages1
JournalArchives of Neurology
Volume67
Issue number9
DOIs
Publication statusPublished - Jan 1 2010
Externally publishedYes

Fingerprint

Cerebral Hemorrhage
Tissue Plasminogen Activator
Stroke
Dabigatran

ASJC Scopus subject areas

  • Arts and Humanities (miscellaneous)
  • Clinical Neurology

Cite this

@article{2db5428230be4b0db0ef99fdf9c0bdb2,
title = "Will symptomatic intracerebral hemorrhages decrease among eligible dabigatran-treated patients who receive intravenous tissue plasminogen activator for acute ischemic stroke?",
author = "Lung Chan",
year = "2010",
month = "1",
day = "1",
doi = "10.1001/archneurol.2010.205",
language = "English",
volume = "67",
journal = "Archives of Neurology",
issn = "0003-9942",
publisher = "American Medical Association",
number = "9",

}

TY - JOUR

T1 - Will symptomatic intracerebral hemorrhages decrease among eligible dabigatran-treated patients who receive intravenous tissue plasminogen activator for acute ischemic stroke?

AU - Chan, Lung

PY - 2010/1/1

Y1 - 2010/1/1

UR - http://www.scopus.com/inward/record.url?scp=77957199008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957199008&partnerID=8YFLogxK

U2 - 10.1001/archneurol.2010.205

DO - 10.1001/archneurol.2010.205

M3 - Letter

VL - 67

JO - Archives of Neurology

JF - Archives of Neurology

SN - 0003-9942

IS - 9

ER -